These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8619576)

  • 21. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM; Biedenbach DJ; Beach ML; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae.
    Pankuch GA; Jueneman SA; Davies TA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2914-8. PubMed ID: 9797225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.
    Thorburn CE; Knott SJ; Edwards DI
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1973-9. PubMed ID: 9687392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.
    Potgieter E; Carmichael M; Koornhof HJ; Chalkley LJ
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):543-6. PubMed ID: 1526239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.
    Doern GV; Ferraro MJ; Brueggemann AB; Ruoff KL
    Antimicrob Agents Chemother; 1996 Apr; 40(4):891-4. PubMed ID: 8849246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study.
    Low DE; de Azavedo J; ; Davidson R
    Can J Infect Dis; 1999 Mar; 10(2):122-7. PubMed ID: 22346377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico.
    Silva J; Aguilar C; Estrada MA; Echániz G; Carnalla N; Soto A; López-Antuñano FJ
    J Chemother; 1998 Apr; 10(2):102-7. PubMed ID: 9603634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
    Pfaller MA; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):273-6. PubMed ID: 9458985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.
    Sader HS; Johnson DM; Jones RN
    Antimicrob Agents Chemother; 2004 Jan; 48(1):53-62. PubMed ID: 14693518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
    Piérard D; de Meyer A; Lauwers S
    Pathol Biol (Paris); 1994 May; 42(5):471-4. PubMed ID: 7824316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Kuriyama T; Karasawa T; Nakagawa K; Nakamura S; Yamamoto E
    Oral Microbiol Immunol; 2002 Oct; 17(5):285-9. PubMed ID: 12354209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x.
    Sifaoui F; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1996 Jan; 40(1):152-6. PubMed ID: 8787897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia.
    Kennedy HF; Gemmell CG; Bagg J; Gibson BE; Michie JR
    J Antimicrob Chemother; 2001 May; 47(5):693-6. PubMed ID: 11328787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.